Assembly Biosciences (ASMB)

Download button icon Download

Assembly Biosciences (ASMB): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY


Where the closing price fall within the day’s trading range highlights whether are in control.

[Calculations] Close Today Versus Range Today (CTRT):
1) When the closing price is near the high of the day buyers were in control at the close of the trading session;
2) When the closing price is near the low of the day sellers were in control at the close of the trading session;
3) When the closing price is near the middle of the day’s range where neither the buyers or sellers were in control at the close of the trading session;


PROFILE: Assembly Biosciences (ASMB)


Stock Exchange: NASDAQ
Company: Assembly Biosciences
Ticker Codes: | ASMB | NASDAQ:ASMB |

About Assembly Biosciences (NASDAQ:ASMB):

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. It develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutic candidates to treat disorders associated with the microbiome in the United States. It is involved in the development of core protein allosteric modulators that modulate the HBV core protein at various points in the viral lifecycle. The company also develops microbiome program, a platform that includes the identification and selection process to strain isolation and growth under current good manufacturing practice conditions; and a patent pending delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. In addition, it engages in the development of product candidates for various disease indications, such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, non-alcoholic steatohepatitis, immuno-oncology, and clostridium difficile infections by using its microbiome platform. It has a collaboration agreement with Allergan Pharmaceuticals International Limited for the development and commercialization of selected microbiome gastrointestinal programs. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana.

Top 10:

Close vs Range

Download button icon Download
Company Close Change (%) Volume Value Signal
BLCM Bellicum Pharma 3.66 0.5 495,867 -1 BEARISH
USLM US Lime & Mineral 74.82 -0.4 2,442 -1 BEARISH
TPIC Tpi Composites 29.13 -0.5 778,635 -1 BEARISH
IRDM Iridium 26.4 -0.9 1,543,399 -1 BEARISH
CYTK Cytokinetics 8.75 -1 468,097 -1 BEARISH
GRBK Green Brick Partners 8.64 -1 85,154 -1 BEARISH
NCMI National Cinemedia 7.28 -1.4 157,171 -1 BEARISH
ARAY Accuray Incorporated 4.71 -1.5 656,209 -1 BEARISH
SPOK Spok Holdings Inc 13.43 -1.7 61,834 -1 BEARISH
LE Lands' End Inc 15.83 -1.8 341,242 -1 BEARISH
back to top